Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gloria S Huang

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology Reports|March 4, 2016
Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumorMelissa Schwartz, Gloria S Huang
Cancer Research|August 17, 2019
Precision Therapy for Aggressive Endometrial Cancer by Reactivation of Protein Phosphatase 2AKaitlin Haines, Gloria S Huang
Frontiers in Oncology|September 2, 2022
Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancerJulia H Gelissen, Gloria S Huang
Cytokine & Growth Factor Reviews|February 24, 2015
IGF2 signaling and regulation in cancerJurriaan Brouwer-Visser, Gloria S Huang
Cancer|May 10, 2017
Genetic landscape of clear cell endometrial cancer and the era of precision medicineGloria S Huang, Alessandro D Santin
Reproductive Sciences (Thousand Oaks, Calif.)|May 13, 2024
ARID1A in Gynecologic Precancers and CancersJaida E Morgan, Nishah Jaferi, Zainab Shonibare, et al.
Gynecologic Oncology|December 7, 2002
Liposomal doxorubicin for treatment of metastatic chemorefractory vulvar adenocarcinomaGloria S Huang, Margrit Juretzka, Giuseppe Ciaravino, et al.
Gynecologic Oncology|August 29, 2009
Extragenital adenosarcoma: a case report, review of the literature, and management discussionGloria S Huang, Rebecca C Arend, Antoinette Sakaris, et al.
Frontiers in Big Data|March 11, 2021
Stratifying Ovarian Cancer Risk Using Personal Health DataGregory R Hart, Bradley J Nartowt, Wazir Muhammad, et al.
Plos One|June 17, 2014
Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancerJurriaan Brouwer-Visser, Jiyeon Lee, KellyAnne McCullagh, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology Reports|March 4, 2016
Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumorMelissa Schwartz, Gloria S Huang
Cancer Research|August 17, 2019
Precision Therapy for Aggressive Endometrial Cancer by Reactivation of Protein Phosphatase 2AKaitlin Haines, Gloria S Huang
Frontiers in Oncology|September 2, 2022
Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancerJulia H Gelissen, Gloria S Huang
Cytokine & Growth Factor Reviews|February 24, 2015
IGF2 signaling and regulation in cancerJurriaan Brouwer-Visser, Gloria S Huang
Cancer|May 10, 2017
Genetic landscape of clear cell endometrial cancer and the era of precision medicineGloria S Huang, Alessandro D Santin
Reproductive Sciences (Thousand Oaks, Calif.)|May 13, 2024
ARID1A in Gynecologic Precancers and CancersJaida E Morgan, Nishah Jaferi, Zainab Shonibare, et al.
Gynecologic Oncology|December 7, 2002
Liposomal doxorubicin for treatment of metastatic chemorefractory vulvar adenocarcinomaGloria S Huang, Margrit Juretzka, Giuseppe Ciaravino, et al.
Gynecologic Oncology|August 29, 2009
Extragenital adenosarcoma: a case report, review of the literature, and management discussionGloria S Huang, Rebecca C Arend, Antoinette Sakaris, et al.
Frontiers in Big Data|March 11, 2021
Stratifying Ovarian Cancer Risk Using Personal Health DataGregory R Hart, Bradley J Nartowt, Wazir Muhammad, et al.
Plos One|June 17, 2014
Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancerJurriaan Brouwer-Visser, Jiyeon Lee, KellyAnne McCullagh, et al.
Pageof 7